Provider Development and Emerging Technologies

New Opportunities in 2023

WITH 2022 IN THE REARVIEW MIRROR, clinical support teams will focus our efforts in 2023 in three main areas:

• Provider development

• Retention

• Increasing efficiency

Clinical support leadership has been restructured to now include a dedicated Adult Specialty Division under the leadership of our Chief Dental Officer, Dr. Sarah Balaster. In

Dr. Don Gallo Chief Clinical Officer Ally Since 2011

addition to Dr. Balaster, we have three new Chief Dental Officers in General Dentistry: Dr. Alex Cardounel, Dr. Edan Blumenthal, and Dr. William Mauthe. They will be joining Dr. Matt Freedman and Dr. Barry Lyon leading the Orthodontic/ Pedodontic Division.

In 2023 Dental Directors in each state will have an increased focus on coaching and mentoring. This emphasis on provider development will help impact turnover as low productivity and tenure are main drivers of doctor turnover.

DCA allied practices onboarded 43 new graduates this year who are enrolled in a group and individual mentorship program under the leadership of Dr. Edan Blumenthal and Joe D’Alessandro. DCA allied practices look to hire approximately 55 new graduates in 2023, which will require the support of senior doctors to help mentor these new grads. If you have an interest, please reach out to a Chief Dental Officer or your Dental Director.

Quarterly CE events are being scheduled across markets to develop DCA allied practice’s providers clinically and new topics of interest are welcomed. The 2023 plan includes semiannual training for entire teams.

In addition to a focus on supporting provider development, clinical support teams continue to look for emerging technology to help DCA allied practices gain efficiencies. Clinical support teams piloted Overjet, an artificial intelligence program that helps identify possible pathology and decay on radiographs. Currently Overjet is driving increased efficiencies in more than 100 DCA-supported locations and continues to improve the ways technology is applied in the market.

Currently, DCA is partnering with Humana on a pilot to use the Overjet technology in lieu of preauthorization.

Earlier this year, DCA supported the launch of a lab pilot in the Massachusetts market with Dr. Matt Haluch, which will provide a higher quality product, reduced turnaround time, and at a savings to DCA allied providers. Early results look very promising.

Clinical support teams will continue through 2023 to look at opportunities to bring CBCT’s and scanners into DCA allied locations.

I look forward to working with all of you in 2023.